Every two years, the global AIDS community gathers to review the progress in fighting HIV/AIDS, and discuss the challenges that still remain. Next week, the 22nd conference will begin in Amsterdam. The last time Amsterdam hosted the event was in 1992, when the world of HIV research, advocacy, and treatment was much different than it is today.

Worldwide collaboration has increased the total number of people accessing antiretroviral (ARV) therapy globally from 15.8 million to more than 20 million in just two years. It is estimated that 70% of people living with HIV know their status. And many countries have completely eliminated mother-to-child transmission of HIV.

While these figures are impressive and encouraging, there is still a long way to go before the threat of HIV/AIDS is ended. Key populations - including sex workers, people who inject drugs, and transgender individuals - often face limited access to testing, treatment and other health services. Continued attention and resources need to be given to these groups.

IDA Foundation is proud to participate in the conference alongside researchers, policy experts, clinicians, and activists. You can find us at booth #229 in the Exhibitor Hall. We'll be sharing information about our HIV/AIDS product range, which includes products for HIV prevention, treatment, and diagnosis. We are also able to offer oncology drugs for AIDS-related cancers, and treatment for hepatitis C. Please come to the booth to learn about these products and all of IDA's services.

You can stay informed about conference news and activities on the AIDS2018 website, and by following @AIDS_2018, #AIDS2018, and @IDA_Foundation on social media.

We look forward to meeting you and welcoming you to Amsterdam!